HMOX1 STR polymorphism and malaria: an analysis of a large clinical dataset.


Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
17 Nov 2022
Historique:
received: 15 07 2022
accepted: 27 10 2022
entrez: 18 11 2022
pubmed: 19 11 2022
medline: 22 11 2022
Statut: epublish

Résumé

Inducible expression of heme oxygenase-1 (encoded by the gene HMOX1) may determine protection from heme released during malaria infections. A variable length, short tandem GT(n) repeat (STR) in HMOX1 that may influence gene expression has been associated with outcomes of human malaria in some studies. In this study, an analysis of the association between variation at the STR in HMOX1 on severe malaria and severe malaria subtypes is presented in a large, prospectively collected dataset (MalariaGEN). The HMOX1 STR was imputed using a recently developed reference haplotype panel designed for STRs. The STR was classified by total length and split into three alleles based on an observed trimodal distribution of repeat lengths. Logistic regression was used to assess the association between this repeat on cases of severe malaria and severe malaria subtypes (cerebral malaria and severe malarial anaemia). Individual analyses were performed for each MalariaGEN collection site and combined for meta-analysis. One site (Kenya), had detailed clinical metadata, allowing the assessment of the effect of the STR on clinical variables (e.g. parasite count, platelet count) and regression analyses were performed to investigate whether the STR interacted with any clinical variables. Data from 17,960 participants across 11 collection sites were analysed. In logistic regression, there was no strong evidence of association between STR length and severe malaria (Odds Ratio, OR: 0.96, 95% confidence intervals 0.91-1.02 per ten GT(n) repeats), although there did appear to be an association at some sites (e.g., Kenya, OR 0.90, 95% CI 0.82-0.99). There was no evidence of an interaction with any clinical variables. Meta-analysis suggested that increasing HMOX1 STR length is unlikely to be reliably associated with severe malaria. It cannot be ruled out that repeat length may alter risk in specific populations, although whether this is due to chance variation, or true variation due to underlying biology (e.g., gene vs environment interaction) remains unanswered.

Sections du résumé

BACKGROUND BACKGROUND
Inducible expression of heme oxygenase-1 (encoded by the gene HMOX1) may determine protection from heme released during malaria infections. A variable length, short tandem GT(n) repeat (STR) in HMOX1 that may influence gene expression has been associated with outcomes of human malaria in some studies. In this study, an analysis of the association between variation at the STR in HMOX1 on severe malaria and severe malaria subtypes is presented in a large, prospectively collected dataset (MalariaGEN).
METHODS METHODS
The HMOX1 STR was imputed using a recently developed reference haplotype panel designed for STRs. The STR was classified by total length and split into three alleles based on an observed trimodal distribution of repeat lengths. Logistic regression was used to assess the association between this repeat on cases of severe malaria and severe malaria subtypes (cerebral malaria and severe malarial anaemia). Individual analyses were performed for each MalariaGEN collection site and combined for meta-analysis. One site (Kenya), had detailed clinical metadata, allowing the assessment of the effect of the STR on clinical variables (e.g. parasite count, platelet count) and regression analyses were performed to investigate whether the STR interacted with any clinical variables.
RESULTS RESULTS
Data from 17,960 participants across 11 collection sites were analysed. In logistic regression, there was no strong evidence of association between STR length and severe malaria (Odds Ratio, OR: 0.96, 95% confidence intervals 0.91-1.02 per ten GT(n) repeats), although there did appear to be an association at some sites (e.g., Kenya, OR 0.90, 95% CI 0.82-0.99). There was no evidence of an interaction with any clinical variables.
CONCLUSIONS CONCLUSIONS
Meta-analysis suggested that increasing HMOX1 STR length is unlikely to be reliably associated with severe malaria. It cannot be ruled out that repeat length may alter risk in specific populations, although whether this is due to chance variation, or true variation due to underlying biology (e.g., gene vs environment interaction) remains unanswered.

Identifiants

pubmed: 36397106
doi: 10.1186/s12936-022-04352-x
pii: 10.1186/s12936-022-04352-x
pmc: PMC9670449
doi:

Substances chimiques

Heme Oxygenase-1 EC 1.14.14.18
HMOX1 protein, human EC 1.14.14.18

Types de publication

Meta-Analysis Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

342

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : Wellcome Trust
ID : GW4CAT
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 202802/Z/16/Z
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Korean J Parasitol. 2018 Apr;56(2):167-173
pubmed: 29742871
PLoS One. 2022 May 12;17(5):e0267399
pubmed: 35551540
Am J Epidemiol. 2010 Sep 15;172(6):631-6
pubmed: 20682519
Am J Epidemiol. 2023 Jul 06;:
pubmed: 37414746
FEBS Lett. 1999 Jul 16;455(1-2):70-4
pubmed: 10428474
Thromb Haemost. 2004 Jan;91(1):155-61
pubmed: 14691581
Jpn J Infect Dis. 2005 Oct;58(5):268-71
pubmed: 16249618
Nat Commun. 2019 Dec 16;10(1):5732
pubmed: 31844061
Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5681-5686
pubmed: 30833408
J BUON. 2015 Jul-Aug;20(4):1142-53
pubmed: 26416069
PLoS One. 2010 Jun 16;5(6):e11141
pubmed: 20585394
Sci Rep. 2022 Aug 29;12(1):14683
pubmed: 36038559
Nat Rev Genet. 2005 Apr;6(4):333-40
pubmed: 15803201
J Biol Chem. 1999 May 7;274(19):13176-80
pubmed: 10224073
J Cell Mol Med. 2017 May;21(5):894-903
pubmed: 27998018
PLoS Pathog. 2012;8(3):e1002579
pubmed: 22438807
Malar J. 2010 Sep 17;9:260
pubmed: 20846452
Cell Host Microbe. 2008 May 15;3(5):331-8
pubmed: 18474360
Free Radic Biol Med. 2004 Oct 15;37(8):1097-104
pubmed: 15451051
Nat Commun. 2018 Oct 23;9(1):4397
pubmed: 30353011
Nat Genet. 2002 Mar;30(3):315-20
pubmed: 11919562
Nat Genet. 2016 Jan;48(1):22-9
pubmed: 26642241
Nat Med. 2007 Jun;13(6):703-10
pubmed: 17496899
Lancet Haematol. 2018 Aug;5(8):e333-e345
pubmed: 30033078
Transplantation. 2016 Jan;100(1):176-83
pubmed: 26680374
PLoS One. 2013 Oct 02;8(10):e77224
pubmed: 24098580
J Matern Fetal Neonatal Med. 2021 Jan;34(1):12-23
pubmed: 30700176
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Infect Immun. 2012 Apr;80(4):1445-54
pubmed: 22290142
Malar J. 2015 Apr 11;14:153
pubmed: 25888733

Auteurs

Fergus Hamilton (F)

MRC Integrative Epidemiology Unit, University of Bristol, Oakfield Grove, Bristol, BS8 2BN, UK. Fergus.hamilton@bristol.ac.uk.
Infection Sciences, North Bristol NHS Trust, Bristol, England, UK. Fergus.hamilton@bristol.ac.uk.

Ruth Mitchell (R)

MRC Integrative Epidemiology Unit, University of Bristol, Oakfield Grove, Bristol, BS8 2BN, UK.

Aubrey Cunnington (A)

Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK.
Centre for Paediatrics and Child Health, Imperial College London, London, UK.

Peter Ghazal (P)

System Immunity Research Institute, Division of Infection and Immunity, Cardiff University, Cardiff, UK.

Nicholas J Timpson (NJ)

MRC Integrative Epidemiology Unit, University of Bristol, Oakfield Grove, Bristol, BS8 2BN, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH